Skip to main content

Sound Advice: November 3, 2021

Medicare 201 

Coverage of outpatient prescription drugs under Medicare Part D began on January 1, 2006.  Part D is an optional plan that is available to everyone enrolled in Medicare Part A and Part B.  There are numerous plans available and there are considerable differences in ongoing plan prices as well as drug costs.

Let’s begin with some basics.  One of the most important is the formulary, the list of prescription drugs (both name brand and generic) preferred by the health plan.  There are copays for those that are on the list.  For drugs not on the list, the patient may have to pay full price.  Formularies change annually and drugs that have been included in the formulary may switch from preferred to nonpreferred or be removed entirely.

Within the formulary there are different tiers for the drugs included.  Tier 1 is generic drugs, which have the lowest possible copayment.  Tier 2 includes brand-name drugs that do not have a generic option.  Tier 3 consists of nonpreferred, brand-name drugs that do have a generic option. Tier 4 includes nonpreferred brand-name drugs and some nonpreferred, high-cost generic drugs.  With Part D coverage, the copayment costs can range from just a few dollars to fairly hefty sums. 

In addition, there are preferred pharmacies.  A preferred pharmacy network is a group of pharmacies willing to give the plans a larger discount than those offered by other pharmacies.

That leads us to the next issue: the stages of coverage.

Stage 1 of Part D is when you pay the full cost of prescriptions until you meet the annual deductible, which may be as little as zero or much higher, depending on the plan selected. 

Stage 2 of Part D is when the plan pays for a portion of the prescription drug you purchase, as long as the drug is covered under the plan’s formulary.  The copay is determined by the tier level assigned to the drug.  This stage ends when the amount spent by you and your plan adds up to the coverage limit set by Medicare for that year.  The limit for 2022 is $4,430.

Stage 3 of Part D is known as the coverage gap (a.k.a., the donut hole) for those whose spending on prescription drugs has exceeded the Stage 2 limit.  When in Stage 3, participants will pay 25% of the plan’s cost for covered brand-name and generic drugs.  Stage 3 ends when the total spending for covered drugs reaches $7,050.  This number is the total of copays, yearly deductible, and what has been paid for drugs in the coverage gap.

Stage 4 of Part D is known as catastrophic coverage.  In this stage, the plan and the government pay for about 95% of the cost.  Participants in Stage 4 remain in this stage until the end of the coverage year. 

For more details, go to medicare.gov.

N. Russell Wayne, CFP®

Sound Asset Management Inc.

Weston, CT  06883

203-222-9370

www.soundasset.com

www.soundasset.blogspot.com

Any questions?  Please contact me at nrwayne@soundasset.com

Comments

Popular posts from this blog

Sound Advice: September 21, 2022

The Professional Approach To Stock Selection There are various approaches to stock selection, but the two that predominate are fundamental analysis and technical analysis.  Fundamental analysis is a numbers-based method that evaluates key factors such as income and financial health, including the past, present, and future.  Technical analysis emphasizes movements and formations of stock prices. Fundamental analysis is based on factors that over time have proved to have a meaningful impact on stock price movements.  The optimal picture of corporate profitability is steady growth, both in the past and, prospectively, in the coming years.  Steady growth is rewarded by higher valuations of underlying earning power than those accorded companies with erratic progress. When professionals screen (filter) the data of the broad universe of stocks, they look for companies that move ahead every year, regardless of the prevailing economic conditions.  Although high pas...

Sound Advice: July 26, 2023

Is Day Trading a Good Idea? Day trading can be both exciting and potentially profitable, but it also comes with significant risks and challenges. Whether it's a good idea depends on several factors, including your financial situation, risk tolerance, time commitment, and knowledge of the markets. Here are some considerations to keep in mind: Risk and volatility: Day trading involves buying and selling securities within a short time frame, often within the same day. This exposes you to the inherent volatility and risks of the market. Prices can fluctuate rapidly, and unexpected events can have a significant impact on stock prices, making it challenging to consistently make profits. Time commitment: Day trading requires a substantial time commitment. It involves closely monitoring market movements, conducting research, and executing trades. It can be stressful and demanding, as you need to be actively engaged in the market during t...

Sound Advice: May 31, 2023

High Yields, Yes!  But There Are Risks Now that failure to get much done in Washington seems to be the bottom line for lots of talk, but little action, it’s hard not to wonder whether we’re missing something.  Yes, the Federal Reserve Board has aggressively raised interest rates in the hope of putting a damper on excessively high inflation, but one would think that there might be some good news as a result of these efforts. The hoped-for result is that inflation is indeed moderating.  Also of importance, though, is the sharp improvement in interest rates on fixed-income investments, usually a.k.a. bonds.  For much of the past decade or more, interest rates have languished at or near historical lows, which created considerable shortfalls for folks living on fixed incomes. Thanks to the Fed’s hikes, the returns on bonds and the like are beginning to be of interest.  But . . . and that’s a big but . . . there are risks involved. For short-term investing at ...